Literature DB >> 31395395

Preoperative Predictors of Achieving Clinically Significant Athletic Functional Status After Hip Arthroscopy for Femoroacetabular Impingement at Minimum 2-Year Follow-Up.

Austin V Stone1, Edward C Beck2, Philip Malloy2, Jorge Chahla2, Benedict U Nwachukwu2, William H Neal2, Shane J Nho3.   

Abstract

PURPOSE: To identify predictors of achieving clinically significant sport function in athletic patients undergoing hip arthroscopy for femoroacetabular impingement syndrome (FAIS).
METHODS: Data were analyzed for all patients who treated for FAIS between 2012 to 2016 and reported being athletes, including recreational and competitive athletes. All patients had a minimum of 2-year follow-up with patient-reported athletic function in the form of the Hip Outcome Score-Sport Specific (HOS-SS), visual analog score-pain, and patient satisfaction. Achieving clinically significant sports function was defined as either reaching the minimally clinical important difference (MCID) or the patient acceptable symptomatic state (PASS) for HOS-SS at 2-year follow-up. An exploratory factor analysis was used to determine specific domains for the predictor variables and to reduce the redundancy in these variables. A logistic regression analysis was used to identify significant predictors of achieving clinically significant sports function [corrected].
RESULTS: Of 780 qualifying patients, 626 completed the 2-year minimum follow-up (80%), with a mean age and body mass index of 31.6 ± 11.9 years and 24.6 ± 8.6, respectively. A total of 500 patients (86.5%) achieved high functional status, with 77.9% achieving MCID HOS-SS and 68.7% achieving PASS HOS-SS. Logistic regression analysis identified increased the α angle (odds ratio [OR] 0.976; P = .027), preoperative pain duration (OR 0.729; P = .011), and body mass index (BMI) (OR 0.919; P = .018), as well as the presence of femoral chondral defects (OR 0.769; P = .013), as negative predictors for achieving MCID. Negative predictors for achieving PASS HOS-SS included the presence of a preoperative limp (OR 0.384; P = .013), anxiety or depression (OR 0.561; P = .041), and increased BMI (OR 0.945; P = .018) and preoperative pain duration (OR 0.987; P < .001).
CONCLUSIONS: Several predictors of achieving clinically significant sport function performance exist, including a history of anxiety or depression, BMI, preoperative α angle, limp, femoral chondral damage, *and preoperative symptom duration. Our results suggest there are both modifiable and nonmodifiable preoperative factors that have the potential to predict achieving high athletic function after hip arthroscopy for FAIS. LEVEL OF EVIDENCE: IV, Case Series.
Copyright © 2019 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31395395     DOI: 10.1016/j.arthro.2019.05.022

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  13 in total

1.  Pain Catastrophizing and Kinesiophobia Affect Return to Sport in Patients Undergoing Hip Arthroscopy for the Treatment of Femoroacetabular Impingement.

Authors:  Robert B Browning; Ian M Clapp; Thomas D Alter; Benedict U Nwachukwu; Shane J Nho
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-05-27

2.  Hip Arthroscopy for Femoroacetabular Impingement: Minimal Clinically Important Difference Rates Decline From 1- to 5-Year Outcomes.

Authors:  Berkcan Akpinar; Lawrence J Lin; David A Bloom; Thomas Youm
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-01-30

3.  Biochemical MRI With dGEMRIC Corresponds to 3D-CT Based Impingement Location for Detection of Acetabular Cartilage Damage in FAI Patients.

Authors:  Till D Lerch; Dimitri Ambühl; Florian Schmaranzer; Inga A S Todorski; Simon D Steppacher; Markus S Hanke; Pascal C Haefeli; Emanuel F Liechti; Klaus A Siebenrock; Moritz Tannast
Journal:  Orthop J Sports Med       Date:  2021-03-19

4.  Arthroscopic Correction of Sports-Related Femoroacetabular Impingement in Competitive Athletes: 2-Year Clinical Outcome and Predictors for Achieving Minimal Clinically Important Difference.

Authors:  Karen Mullins; David Filan; Patrick Carton
Journal:  Orthop J Sports Med       Date:  2021-03-04

Review 5.  Evaluation of outcome reporting trends for femoroacetabular impingement syndrome- a systematic review.

Authors:  Ida Lindman; Sarantos Nikou; Axel Öhlin; Eric Hamrin Senorski; Olufemi Ayeni; Jon Karlsson; Mikael Sansone
Journal:  J Exp Orthop       Date:  2021-04-23

6.  How Many Patients Achieve an Acceptable Symptom State After Hip Arthroscopy for Femoroacetabular Impingement Syndrome? A Cross-sectional Study Including PASS Cutoff Values for the HAGOS and iHOT-33.

Authors:  Lasse Ishøi; Kristian Thorborg; Marie G Ørum; Joanne L Kemp; Michael P Reiman; Per Hölmich
Journal:  Orthop J Sports Med       Date:  2021-04-09

7.  Intraoperative Guidance for the Surgical Correction of Cam Deformities Using Hip Arthroscopy Based on Alpha Angle Measurement.

Authors:  Safa Gursoy; Amar S Vadhera; Harsh Singh; Allison Perry; Shane J Nho; Jorge Chahla
Journal:  Arthrosc Tech       Date:  2021-04-26

8.  Mood Disorders Are Associated with Increased Perioperative Opioid Usage and Health Care Costs in Patients Undergoing Knee Cartilage Restoration Procedure.

Authors:  Austin V Stone; Meredith L Murphy; Cale A Jacobs; Christian Lattermann; Gregory S Hawk; Katherine L Thompson; Caitlin E W Conley
Journal:  Cartilage       Date:  2022 Jan-Mar       Impact factor: 3.117

9.  What is the Role of Kinesiophobia and Pain Catastrophizing in Outcomes After Hip Arthroscopy for Femoroacetabular Impingement Syndrome?

Authors:  Ian M Clapp; Benedict U Nwachukwu; Edward C Beck; Jonathan P Rasio; Thomas Alter; Bradley Allison; Shane J Nho
Journal:  Arthrosc Sports Med Rehabil       Date:  2020-01-08

10.  Radiographic Factors Associated With Failure of Revision Hip Arthroscopy.

Authors:  David A Bloom; Stephen W Yu; Matthew T Kingery; Nainisha Chintalapudi; Christopher Looze; Thomas Youm
Journal:  Arthrosc Sports Med Rehabil       Date:  2020-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.